
USPH Stock Forecast & Price Target
USPH Analyst Ratings
Bulls say
US Physical Therapy is a well-capitalized company with a strong balance sheet and cash flow, allowing them to continue their acquisition and de novo (new clinic) expansion strategy. Their recent acquisition and partnership agreements with hospitals and medical facilities show potential for increased revenue and profitability in the long term. However, there are potential risks such as reimbursement pressure from Medicare and economic fluctuations that could negatively impact profitability and growth. Overall, US Physical Therapy's strong financials and growth potential make it an attractive investment opportunity.
Bears say
US Physical Therapy is facing challenges in the short term, including a decrease in patient visits and revenue due to weather and the loss of partnership opportunities. Additionally, their IIP business may see a slowdown in growth due to the impact of weather and the recent acquisition. These factors, along with the high costs of salaries and operating expenses, may lead to decreased profitability in the near future. Furthermore, their reliance on managed care programs and workers' compensation insurance may make their revenue stream unstable in times of economic downturn.
This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.
USPH Analyst Forecast & Price Prediction
Start investing in USPH
Order type
Buy in
Order amount
Est. shares
0 shares